1. In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Issue 5 (4th September 2015) Authors: Rolf, Michael G.; Curwen, Jon O.; Veldman‐Jones, Margaret; Eberlein, Cath; Wang, Jianyan; Harmer, Alex; Hellawell, Caroline J.; Braddock, Martin Journal: Pharmacology research & perspectives Issue: Volume 3:Issue 5(2015:Oct) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗